Rezvan Moniri

Dept. Microbiology, Faculty of Medicine, Kashan University of Medical Sciences

Email:

Summary

  • Professor of Medical Microbiology
  • Highly skilled in teaching students and make them understand the subject
  • Extensive experience in establishing and running scientific research groups.
  • Demonstrated ability to lead a major independent research program.
  • Excellent interpersonal and communication skills

Highlights

  • Microbiological techniques
  • Antibiotic susceptibility tests
  • Immunoflurescence assay expertise
  • DNA isolation expert
  • Primer design
  • PCR and western blotting
  • Knowledgeable about subcloning
  • Leader in data presentation
  • Expert in data analyzing
  • Fluent in English, Persian farsi Native or bilingual proficiency, Arabic Elementary proficiency, Turkish Limited working proficiency

Accomplishments

  • Over twenty five years of experience in the field of education (both teaching and administrating) for medical college level, M.S. and PhD students
  • Served as supervisor of Central laboratory for a 25 years
  • Implemented a new molecular laboratory which became a leader in Kashan University of Medical Sciences
  • Conducted experiments to achieve microbiology research objectives
  • Supervised lab technicians, technologist and other scientist.
  • Conducted research in bacterial pathogenesis and antibiotic resistance
  • Led 20 research associate and worked closely with colleagues

Experience

  • Taught medical microbiology at faculty of medicine, Kashan University of Medical Sciences, Kashan, Iran January 1992 to April 2015
  • Worked as supervisor at central clinical laboratory, Kashan University of Medical Sciences, Kashan, Iran January 1992 to April 2015
  • Researched at Anatomical Sciences Research Center, Kashan University of Medical Sciences, Kashan, Iran, March 2010 to now
  • Worked as FLSP in virology at Dr. Chetankumar (Chet) Tailor’s lab at SickKids hospital, Toronto, Canada, March 2003 to October 2003
  • Associate Editor of Jundishapur Journal of Microbiology Apri 2011-Now

Education

Tehran University of Medical Sciences 1988- 1992

Ph. D in Medical Microbiology

Tehran, Iran

Faculty of Veterinary Medicine, Shiraz University, 1979- 1987

DVM, Doctor of Veterinary Medicine

Shiraz, Iran

Publications

Conference papers

1. Invited Congress. 47th Annual ICAAC Chicago Sept. 17-20, 2007. Effective Risk Factors for Colonization of Extended-Spectrum ß-Lactamase Producing Gram-Negative Bacilli in Hospitalized Neonates

2. Invited Congress. 46th Annual ICAAC San Francisco Sept. 27-30, 2006. The Evaluation of Bacterial Contamination of Medical Devices and Anti-Bacterial Resistance of Isolated Gram Negative Bacilli

3. Invited Congress. The 13th Congress of the European Academy of Dermatology and Veneralogy, Florence, Italy. JEADV volume 18, Supplement 2, Nov.17-21, 2004. Risk factors for surgical sites infections.

4. Invited Congress. IFIC Scolarship award. The Fifth Congress of the International Fedration of Infection Control. October 9-12, 2004. Porec, Croatia. Rate and risk factors of surgical site infections with antibiotic prophylaxis.

5. Invited Symposium. The 13th international symposium on HIV and emerging infectious diseases, June 3-5, 2004. Toulon, France. Screening of Iranian blood donors for transfusion transmitted infections.

6. Invited Conference. The Fifth (V) IACMAC in Antimicrobial Conference, “Antimicrobial Therapy”, June 4-6, 2002. Moscow, Russia. Increase resistance of E. coli isolated from patients with urinary tract infections against antimicrobial agents.

7. Invited Congress Speaker: The First Iranian Congress on Virology Feb.19-21, 2002. Tehran University of Medical Sciences. Seroprevalence of Cytomegalovirus IgM antibody in blood donor population in kashan.

8. Invited Conference Speaker: The First Iranian Congress on Virology Feb.19–21, 2002. Tehran University of Medical Sciences. The survey on epidemiology of Congo-Crimean Hemorrhagic Fever in Iran.

9. Invited Conference: The 42nd Inter-science Conference on Antimicrobial Agents and Chemotherapy, San Diego Convention Center, California, USA. Sep. 27-30, 2002. The Survey on Isolated Multi-drug Resistance Strains of Mycobacterium tuberculosis in Iran.

Publications

Journal articles

  1. Goli YD, Moniri R.Efficacy of probiotics as an adjuvant agent in eradication of Helicobacter pylori infection and associated side effects. Benef Microbes. 2016 May 31:1-10
  2. Amiri A, Firoozeh F, Moniri R, Zibaei M. Prevalence of CTX-M-Type and PER Extended-Spectrum β-Lactamases Among Klebsiella spp. Isolated From Clinical Specimens in the Teaching Hospital of Kashan, Iran.Iran Red Crescent Med J. 2016 Mar 27;18(3):e22260. doi: 10.5812/ircmj.22260. eCollection 2016 Mar.
  3. Safary A, Moniri R, Hamzeh-Mivehroud M, Dastmalchi S. A strategy for soluble overexpression and biochemical characterization of halo-thermotolerant Bacillus laccase in modified E. coli.J Biotechnol. 2016 Jun 10; 227:56-63. doi: 10.1016/j.jbiotec.2016.04.006. Epub 2016 Apr 5.
  4. Bagheri Josheghani S, Moniri R, Firoozeh F, Sehat M, Dasteh Goli Y.Susceptibility Pattern and Distribution of Oxacillinases and bla PER-1 Genes among Multidrug Resistant Acinetobacter baumannii in a Teaching Hospital in Iran.J Pathog. 2015; 2015:957259. doi: 10.1155/2015/957259.
  5. Shams E, Firoozeh F, Moniri R, Zibaei M. Prevalence of Plasmid-Mediated Quinolone Resistance Genes among Extended-Spectrum β -Lactamase-Producing Klebsiella pneumoniae Human Isolates in Iran.J Pathog. 2015;2015:434391. doi: 10.1155/2015/434391.
  6. Afzali H, Moniri R, et al. Characterization of CTX-M-Type Extend-Spectrum β-Lactamase Producing Klebsiella spp. in Kashan, Iran. Jundishapur J of Microbiol. 2015; 8(10):e27967
  7. Kashani HH, Moniri R. Expression of Recombinant pET22b-LysK-Cysteine/Histidine-Dependent Amidohydrolase/Peptidase Bacteriophage Therapeutic Protein in Escherichia coli BL21 (DE3).Osong Public Health Res Perspect. 2015 Aug;6(4):256-60. doi: 10.1016/j.phrp.2015.08.001.
  8. Iravani Mohammad Abadi M. Moniri R. Molecular characteristics of nasal carriage methicillin-resistant coagulase negative Staphylococci among school students. Jundishapur J Microbiol .Jundishapur J Microbiol. 2015; 8(6): e18591.
  9. Afrasiabi S, Moniri R, et al. The Prevalence of Endocervical Chlamydia trachomatis Infection among Young Females in Kashan, Iran. Jundishapur J Microbiol.2015; 8(4):e15576.
  10. Sharif F, Moniri R, et al. Antibiotic Susceptibility Patterns and blaPER-1 beta-lactamase producing Acinetobacter baumannii isolated from hospitalized patients. Journal of Global Antimicrobial Resistance 3 (2015) pp. 47-48.
  11. Keshavarz Azizi Raftar S, Moniri R, et al. The Helicobacter pylori Resistance Rate to Clarithromycin in Iran. Microb Drug Resist. 2015 Feb; 21(1):69-73.
  12. Rezaei M, Moniri R, et al. Molecular analysis and susceptibility pattern of meticillin-resistant Staphylococcus aureus strains in emergency department patients and related risk factors in Iran. J Hosp Infect. 2015 Jan 7. pii: S0195-6701(15)00013-4.
  13. Erami M, Moniri R. Nasal Carriage and Resistance Pattern of Multidrug Resistant Staphylococcus aureus Among Healthy Children in Kashan, Iran. Iran Red Crescent Med J. 2014;16(9):e21346.
  14. Soltani B, Moniri R, et al. Risk Factors for Methicillin Resistant Staphylococcus aureus Nasal Colonization of Healthy Children. Jundishapur J Microbiol. 2014 Sep; 7(9):e20025.
  15. Mirzaei Ghazi Kalayeh H, Moniri R, et al. Serotyping, Antibiotic Susceptibility and Related Risk Factors Aspects of Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy School Students. Iranian J Publ Health, 43(9) 2014:1284-129.
  16. Keshavarz Azizi Raftar S, Moniri R, et al. The Helicobacter pylori resistance rate to ciprofloxacin in Iran. Int J Antimicrob Agents. 2014 Jun; 43(6):573-4.
  17. Sedaghat H, Moniri R, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2, and oipA genotypes in patients with upper gastrointestinal diseases. 2014; Iran J Microbiol.6(1):14-21.
  18. Afrasiabi S, Moniri R, et al. The frequency of Neisseria gonorrhoeae endocervical infection among female carrier and changing trends of antimicrobial susceptibility patterns in Kashan, Iran. Iran J Microbiol. 2014 Jun; 6(3):194-7.
  19. Safary A, Moniri R, et al. Phylogenetic and biochemical characterization of a new halo-thermotolerant, biofilm-forming Bacillus from Saline Lake of Iran. Pol J Microbiol. 2013; 62(4):419-25.
  20. Doakhan S, Moniri R, et al. Influence of sericin/TiO₂ nanocomposite on cotton fabric: part 1. Enhanced antibacterial effect. Carbohydr Polym. 2013; 94(2):737-48.
  21. Rezaei M, Moniri R, et al. Prevalence of biofilm formation among methicillin resistance staphylococcus aureus isolated from nasal carriers. Jundishapur J Microbiol. 2013, 6 (6): e9601 DOI: 10.5812/jjm.9601
  22. Tavajjohi Z, Moniri R, Detection of GES-2, a Class of A β-Lactamase from Pseudomonas aeruginosa in a teaching hospital in Iran. Jundishapur J Microbiol. 2013, 6 (10):e8166.
  23. Moniri R, et al.Virulence genes relationship with biofilm formation and detection of aac(6’) / aph(2”) in E.faecalis isolated from patients with urinary tracts infection. Jundishapur J Microbiol. 2013, 6(5): 6244. DOI: 10.5812/jjm.6244
  24. Khaltabadi Farahani R, Moniri R, et al. Multi-Drug Resistant Acinetobacter-Derived Cephalosporinase and OXAsetC Genes in Clinical Specimens of Acinetobacter spp. Isolated From Teaching Hospital. Jundishapur J Microbiol. 2013, 6(2): 181-185.
  25. Tavajjohi Z, Moniri, R, et al. Detection and characterization of multidrug resistance and extended-spectrum-beta-lactamase-producing (ESBLs) pseudomonas aeruginosa isolates in teaching hospital.2011. African Journal of Microbiology Research, 5(20) 3223-3228.
  26. Moniri R, Tavajjohi Z. Detection of ESBLs and MDR in Pseudomonas aeruginosa in a tertiary-care teaching hospital. Iranian Journal of Clinical Infectious Diseases, 2011; 6(1): 18-23.
  27. Khorshidi A, Moniri R, et al. The prevalence and molecular characterization of extended-spectrum ß-lactamases-producing Klebsiella pneumoniae isolates recovered from Kashan hospital university, Iran. Jundishapur J Microbiol.2011; 4(4):289-294.
  28. Ghaffarpasand I, Moniri R, et al. Antibiotic resistance in fecal enterococci in hospitalized patients. Indian journal of pathology and Microbiology 2010; 53(4):898-899.
  29. Khorshidi A, Moniri R, et al. Comparison of culture and microscopic methods by PCR for detection of Mycobacterium tuberculosis in sputum. Iranian Journal of Clinical Infectious Diseases. 2009; 4(4):228-232.
  30. Moniri R, et al. Molecular Epidemiology of Aminoglycosides Resistance in Acinetobacter Spp. with Emergence of Multidrug-Resistant Strains. Iranian J Publ Health, Vol. 39, No.2, 2010, pp.63-68.
  31. Moniri R, Behrashi M. Effects of metronidazole therapy on preterm labor in women with bacterial vaginosis. Acta Medica Iranica. Volume 47, Issue 3, 2009, Pages 181-184.
  32. Rohani M, Moniri R, et al. Beijing genotype and other predominant Mycobacterium tuberculosis spoligotypes observed in Mashhad city, Iran. Indian Journal of Medical Microbiology Volume 27, Issue 4, 1 October 2009, Pages 306-310.
  33. Khorshidi A, Moniri R, et al. Comparison of culture and microscopic methods by PCR for detection of Mycobacterium tuberculosis in sputum. Iranian Journal of Clinical Infectious Diseases 2009; 4(4):228-232.
  34. Moniri R, et al. Isolation and identification of Malassezia spp.in Pytiriasis versicolor in Kashan, Iran. Pak J Med Sci. 2009(Part-I), 25 (5):837-840.
  35. Moniri R, et al. The prevalence of nasal carriage methicillin-resistant Staphylococcus aureus in hospitalized patients. Pak J Med Sci. 2009. 25(4):656-659.
  36. Nazeri M, Moniri R, et al. Antifungal activities of fluconazole and ketoconazole agents. Journal of Mazandaran University of Medical Sciences, Vol.18 N.69, 2009: 22-27.
  37. Moniri R. et al. Increasing Resistant Coagulase Negative Staphylococci in Bovine Clinical Mastitis, Pakistan Journal of Biological Sciences, 2007, 10(15):2465-2469
  38. Moniri R., Dastehgoli K. Antimicrobial Resistance among Escherichia coli Strains Isolated from Healthy and Septicemic Chickens, Pakistan Journal of Biological Sciences 10(7):2984-2987.
  39. Movahedian AH, Moniri R, Mosayebi Z. Bacterial culture of neonatal sepsis. Iranian J Publ health, 2006, vol.35, No. 4: 84-89.
  40. Moniri R, et al. Increasing trend of antimicrobial drug-resistance in Pseudomonas aeroginosa causing septicemia. Iranian J Publ health, 2006, vol.35, No. 1:58-62.
  41. Moniri R, Dastehgoli K. Fluoroquinolone-resistant Escherichia coli isolated fromhealthy broilers with previous exposure to fluoroquinolones: Is there a link? 2005. Microbial Ecology in Health and Disease, Volume 17, Number 2, July, pp. 69 - 74.
  42. Moniri R, et al. Emergence of Multi-Drug-Resistant Pseudomonas aeroginosa isolates in neonatal septicemia. 2005. J. Infect. Dis. Antimicrob. Agents. Vol.22, No. 1, Jan- Apr. 39-44.
  43. Moniri R, et al. Seroprevalence of cytomegalovirus, hepatitis B, hepatitis C, and human immunodeficiency virus antibodies among volunteer blood donors. 2004. Iranian J Publ health. vol.33, No.4:38-42.
  44. Moniri R, et al. Emergence of multidrug resistant strains of Escherichia coli isolated from urinary tract infections. 2003. Iranian J Publ health, Vol.32, No. 4, 42-46.
  45. Mosayebi Z, Movahedian A. H., Moniri R. profile of bacterial sepsis in neonates from Kashan in Iran. 2003. J Infect Dis Antimicrob. Agents. vol.20, No. 2:97-102

Interest

  • Pathogenesis of Bacterial infections( H. pylori, P. aeroginosa, Acientobacter, S. aureus)
  • Molecular diagnosis
  • Antibiotic resistance( ESBLs, MRSA, VRE, MDR, XDR)

References (available in request); thanking you in anticipation